Activity Overview
The purpose of this activity is to offer participants recertification credits for the Board of Pharmacy Specialty (BPS) certification for compounded sterile preparations practitioners (BCSCP) by providing a review of pertinent topics.
This selected reading module focuses on centralized insourcing of compounding, analysis of US FDA Warning Letters issued to compounding pharmacies, the impact of technology-assisted sterile compounding on safety and efficiency, and in vitro and Y-site compatibility of calcium chloride with various medications
This activity is approved for 4.0 contact hours of continuing pharmacy education credit. Successful completion of the learning module will provide 4.0 contact hours of continuing pharmacy education credit.
Accreditation for Pharmacists
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
Target Audience
This activity is intended for Board Certified Compounded Sterile Preparations Pharmacy Specialists in need of recertification credit.
Recertification Credit
Board certified pharmacists are eligible to receive up to 4 contact hours of recertification credit for completing this course. To earn recertification credit, learners must review the course content and successfully complete the online assessments by the deadline. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.
This course is not intended for those preparing to take the BPS Compounded Sterile Preparations Pharmacy Specialty Examination for Certification.
This activity is part of the ASHP professional development program for BCSCP recertification approved by the BPS.
|
Learning Activity |
|
Compounded Sterile Preparations Specialty Selected Readings: Calcium Chloride Compatibility, Technology-Assisted vs. Manual Compounding, Centralized Insourcing, and Analysis of FDA Warning Letters Issued Against Compounding Pharmacies (Cert # L239240)
ACPE #: 0204-0000-23-982-H07-P
Contact Hours: 4.0 ACPE
Assessment Pass Point: 75% |
|
Recertification Assessment, 4.0 BPS |
Methods and CE Requirements
Activities consist of educational materials, assessments, and activity evaluations. In order to receive continuing pharmacy education credit, learners must:
- Complete the attestation statement
- Review all content
- Complete and pass the assessments
- Complete the evaluations
Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.
System Technical Requirements
Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating web sites.
View the minimum technical and system requirements for learning activities.
Development
These activities were developed by ASHP.